Antihistaminic activity of 4-(2, 1, pyrrolidino-ethoxy) quinoline.
D000772:Anesthesia, Local; D000818:Animals; D001986:Bronchial Spasm / Q000188:drug therapy; D004487:Edema / Q000188:drug therapy; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006614:Hindlimb; D006634:Histamine H1 Antagonists; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D011113:Polymyxins / Q000037:antagonists & inhibitors; D011759:Pyrrolidines / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D011804:Quinolines / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D013276:Stomach Ulcer / Q000188:drug therapy; D014132:Trachea / Q000187:drug effects
D006634:Histamine H1 Antagonists; D011113:Polymyxins; D011759:Pyrrolidines; D011804:Quinolines